Article Text

Download PDFPDF
Novel Olig 1-coding variants and susceptibility to multiple sclerosis
  1. A Goris,
  2. T W Yeo,
  3. M Maranian,
  4. A Walton,
  5. M Ban,
  6. J Gray,
  7. A Compston,
  8. S Sawcer
  1. Neurology Unit, Department of Clinical Neurosciences, University of Cambridge, Cambridge, UK
  1. Correspondence to:
 A Goris
 Department of Clinical Neurosciences, Neurology Unit, Box 165, Addenbrooke’s Hospital, Hills Road, Cambridge CB2 2QQ, UK; ag441{at}

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Olig1 is a basic helix–loop–helix (bHLH) transcription factor expressed in cells of the oligodendrocyte lineage in the nervous system. Its role during normal development has not yet been fully resolved, but it is known that in adult life the protein is crucial in the process of remyelination after injury.1–3 Olig1 translocates from the cytoplasm to the nucleus in early remyelinating lesions in rodent models of demyelinating disease as well as in oligodendrocyte precursor cells at the edge of multiple sclerosis lesions.1 Olig1 specifically regulates the expression of the major myelin-specific genes during oligodendrocyte maturation in the brain,2 and remyelination after injury is impaired in Olig1-/- mice.1 In patients with multiple sclerosis, remyelinating capacity is limited even though oligodendrocyte precursor cells are often efficiently recruited.4 These findings raise the question whether genetic variants in the Olig1 gene (Olig1) influence remyelinating capacity and vulnerability to …

View Full Text


  • AG is a postdoctoral fellow of the Research Foundation - Flanders (FWO—Vlaanderen).

  • Published Online First 4 July 2006

  • Competing interests: None.